The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms

miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts

(2012) H. Matthaei et al.   CLINICAL CANCER RESEARCH

MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

(2011) N. B. Jamieson et al.   CLINICAL CANCER RESEARCH

Why, When, and How Should Pharmacogenetics Be Applied in Clinical Studies?: Current and Future Approaches to Study Designs

(2011) J C Stingl (formerly Kirchheiner) et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice

(2011) Elisa Giovannetti et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis

(2011) Xiaonan Fu et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer

(2011) Niccola Funel et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Intraductal papillary mucinous neoplasm

(2011) Chanjuan Shi et al.   HUMAN PATHOLOGY

Survival after Resection for Invasive Intraductal Papillary Mucinous Neoplasm and for Pancreatic Adenocarcinoma: A Multi-Institutional Comparison According to American Joint Committee on Cancer Stage

(2011) Joshua A. Waters et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma

(2011) Ji Kon Ryu et al.   PANCREATOLOGY

Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

(2011) J. Wu et al.   Science Translational Medicine

Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas

(2011) Toru Furukawa et al.   Scientific Reports

Analysis of Prognostic Factors and a Proposed New Classification for Invasive Papillary Mucinous Neoplasms

(2010) Jin-Young Jang et al.   ANNALS OF SURGICAL ONCOLOGY

Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma

(2010) Nabil Wasif et al.   CANCER

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

(2010) Nils Habbe et al.   CANCER BIOLOGY & THERAPY

MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity

(2010) Elisa Giovannetti et al.   CANCER RESEARCH

Intraductal Papillary Mucinous Neoplasms of the Pancreas

(2010) Carlos Fernández–del Castillo et al.   GASTROENTEROLOGY

Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma

(2010) Adam D. Toll et al.   HUMAN PATHOLOGY

Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection

(2010) John P. Neoptolemos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

(2010) Pedro P. Medina et al.   NATURE

Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer

(2010) Jin-Hyeok Hwang et al.   PLoS One

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

(2009) Thomas Greither et al.   INTERNATIONAL JOURNAL OF CANCER

Adjuvant Chemoradiotherapy After Pancreatic Resection for Invasive Carcinoma Associated With Intraductal Papillary Mucinous Neoplasm of the Pancreas

(2009) Michael J. Swartz et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Invasive intraductal papillary-mucinous neoplasm of the pancreas: Comparison with pancreatic ductal adenocarcinoma

(2009) Yoshiaki Murakami et al.   JOURNAL OF SURGICAL ONCOLOGY

MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance

(2009) T. Moriyama et al.   MOLECULAR CANCER THERAPEUTICS

Antisense Inhibition of microRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma

(2009) Jong-Kook Park et al.   PANCREAS

Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2

(2008) A. V. Ougolkov et al.   CLINICAL CANCER RESEARCH

Analysis of MicroRNAs in Pancreatic Fine-Needle Aspirates Can Classify Benign and Malignant Tissues

(2008) A. E. Szafranska et al.   CLINICAL CHEMISTRY

MicroRNAs modulate the chemosensitivity of tumor cells

(2008) P. E. Blower et al.   MOLECULAR CANCER THERAPEUTICS

Outcome of Invasive and Noninvasive Intraductal Papillary-Mucinous Neoplasms of the Pancreas (IPMN): A 10-year Experience

(2008) Marco Niedergethmann et al.   WORLD JOURNAL OF SURGERY